Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunovant (IMVT) Change in Receivables (2021 - 2026)

Immunovant filings provide 5 years of Change in Receivables readings, the most recent being -$319000.0 for Q4 2025.

  • Quarterly Change in Receivables fell 261.93% to -$319000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$508000.0 through Dec 2025, down 151.16% year-over-year, with the annual reading at -$3.2 million for FY2025, 170.61% down from the prior year.
  • Change in Receivables hit -$319000.0 in Q4 2025 for Immunovant, down from $25000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $7.5 million in Q4 2021 and bottomed at -$9.8 million in Q3 2022.
  • Average Change in Receivables over 5 years is $41631.6, with a median of $25000.0 recorded in 2025.
  • The largest annual shift saw Change in Receivables plummeted 5616.38% in 2022 before it surged 207100.0% in 2024.
  • Immunovant's Change in Receivables stood at $7.5 million in 2021, then plummeted by 139.11% to -$2.9 million in 2022, then surged by 90.97% to -$266000.0 in 2023, then surged by 174.06% to $197000.0 in 2024, then plummeted by 261.93% to -$319000.0 in 2025.
  • Per Business Quant, the three most recent readings for IMVT's Change in Receivables are -$319000.0 (Q4 2025), $25000.0 (Q3 2025), and -$129000.0 (Q2 2025).